Equities researchers at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a note issued to investors on Saturday. The firm set a “buy” rating on the stock.
Mannatech Stock Down 8.0 %
Shares of NASDAQ:MTEX opened at $9.85 on Friday. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. Mannatech has a fifty-two week low of $6.75 and a fifty-two week high of $16.49. The stock has a market cap of $18.72 million, a price-to-earnings ratio of -12.15 and a beta of 0.98. The firm’s 50 day moving average price is $10.14 and its 200 day moving average price is $10.25.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings results on Wednesday, March 26th. The company reported $1.20 earnings per share for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The company had revenue of $29.01 million for the quarter.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Further Reading
- Five stocks we like better than Mannatech
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- With a 60%+ Upside, There’s Plenty to Love About Lovesac
- Why Are These Companies Considered Blue Chips?
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- The 3 Best Blue-Chip Stocks to Buy Now
- AppLovin: Can Record Profits Overcome Market Skepticism?
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
